Please login to the form below

Not currently logged in
Email:
Password:

British National Formulary moves to NICE

The National Institute for Health and Clinical Excellence is to take over responsibility for the British National Formulary from the Department of Health

The National Institute for Health and Clinical Excellence (NICE) is to take over responsibility for the British National Formulary (BNF) from the Department of Health (DH).

The move comes as a result of the Darzi review and the establishment of a new service, NHS Evidence, which aims to bring clinical information and evidence together, offering healthcare professionals and patients good quality information in one place.

As the independent organisation responsible for providing national guidance on public health, health technologies and clinical practice, NICE will take over responsibility for the BNF.

Dr Gillian Leng, interim chief operating officer for NHS Evidence and NICE deputy chief executive, said: "We are delighted that the BNF will become a key part of NHS Evidence at NICE. NICE is looking forward to working in partnership with the BNF to ensure that it continues to provide high quality and clinically relevant advice."

The BNF provides independent, authoritative information about the use of medicines and is a key reference source for doctors, pharmacists and other healthcare professionals.
 

16th December 2008

From: Healthcare

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

OPEN Health expands offering with the launch of a new Learning & Development specialist team
Enhanced expertise to deliver impactful internal training programmes for healthcare clients...
Figure 1 Clarivate
The changing nature of approvals – what does the future hold?
The 2019 CMR International Pharmaceutical R&D Factbook...
Spotlight interview: 15 minutes on healthcare communications in gene therapy
Gavin Jones, Director of Rare Disease, OPEN Health takes 15 minutes to answer some key questions on healthcare communications in gene therapy...

Infographics